Venture Capital

Dr. David Rankey joins Wellvana as CMO, a strategic move as the company scales its model and the industry shifts from proof of concept to performance.

With new SAFE financing, Cubit Diagnostics advances its all-in-one molecular and immunoassay platform, aiming to revolutionize point-of-care STI testing.

With its new CCO, the AI health-tech firm aims to commercialize its patient-data platform, tackling billion-dollar delays in drug development.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

Digital dentistry leader Medit acquires Progressive Orthodontics, launching a new division to merge high-tech scanning with world-class clinical training.

With $30M in new funding, Lunar Outpost is accelerating its robotic fleet to build the critical infrastructure for a permanent lunar economy and human presence.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

In just eight months, Propelis achieved full operational independence. Here’s how a strategic carve-out became a blueprint for speed and modernization.

ESR secures its fourth consecutive Red Dot Design Award, proving that innovative accessories are essential tools for today's flexible work and study life.

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A Miami hackathon united sheriffs, tech experts, and justice-impacted leaders to tackle recidivism and unlock an untapped workforce for Florida.

A leading scientific body is ditching 'longevity' for 'geroscience,' aiming to bring scientific rigor to a field rife with hype and misinformation.

QuasarEdge Acquisition Corp. signed a non-binding letter to acquire AI firm Robseek, but the deal faces the high risks inherent in speculative SPAC mergers.

Singapore's Video Rebirth launches BACH, a powerful AI video engine that promises precise directorial control and has already ranked among the world's best.

A unique charity raffle offers 25 hours on a private jet, using luxury travel to fund critical nursing education and resources in developing nations.

Quebec biotech firm Aplantex secures $5M to scale its unique green technology, moving from research to industrial production of sustainable ingredients.

With a massive new war chest, the secretive Multi Investment plans to pour capital into fintech, deep tech, and biotech, shaking up innovation funding.

Fueled by a $100M R&D investment, Chinese beauty giant Yatsen is leading a market shift from price wars to scientific innovation, winning global consumers.

The diagnostics firm's stellar quarter is fueled by surging test volumes and a new non-invasive prenatal test poised to disrupt high-risk screening.

Rice University is massively expanding its faculty and student body while vowing to keep its intimate feel. Is "personalized scale" possible or a paradox?